On a serious note, Keep an eye on MMM: good PE, solid Div ratio, hitting recent lows. Downside, 2022 may be a slow year less N95 sales but still profitable at around $10+/Share. Potential liabilities with recent ear plug cases. "Suspect" that will fade from the spotlight, but not sure.
Last edited by TNGary; 02-20-2022 at 02:11 PM.
|